Search results for "INFECTIONS"

showing 10 items of 2671 documents

Recent Advances on the Innate Immune Response to Coxiella burnetii.

2021

Coxiella burnetii is an obligate intracellular Gram-negative bacterium and the causative agent of a worldwide zoonosis known as Q fever. The pathogen invades monocytes and macrophages, replicating within acidic phagolysosomes and evading host defenses through different immune evasion strategies that are mainly associated with the structure of its lipopolysaccharide. The main transmission routes are aerosols and ingestion of fomites from infected animals. The innate immune system provides the first host defense against the microorganism, and it is crucial to direct the infection towards a self-limiting respiratory disease or the chronic form. This review reports the advances in understanding…

Microbiology (medical)LipopolysaccharidesImmunologyexperimental modelcytokine—immunological termsQ feverimmunotherapeuticReviewMicrobiologyMicrobiologyImmune systemCellular and Infection MicrobiologyToll-like receptorinflammasomeautophagiamedicineAnimalsHumansPathogeninnate immunityInnate immune systemObligatebiologyTransmission (medicine)MacrophagesInflammasomeCoxiella burnetiibiology.organism_classificationmedicine.diseasebacterial infections and mycosesImmunity InnateQR1-502Toll-like receptorsimmunotherapeuticsInfectious DiseasesCoxiella burnetiibacteriaQ Fevercytokine—immunological termmedicine.drug
researchProduct

Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study

2022

INTRODUCTION: Intra-abdominal infections represent the second most frequently acquired infection in the intensive care unit (ICU), with mortality rates ranging from 20% to 50%. Candida spp. may be responsible for up to 10-30% of cases. This study assesses risk factors for development of intra-abdominal candidiasis (IAC) among patients admitted to ICU. METHODS: We performed a case-control study in 26 European ICUs during the period January 2015-December 2016. Patients at least 18 years old who developed an episode of microbiologically documented IAC during their stay in the ICU (at least 48 h after admission) served as the case cohort. The control group consisted of adult patients who did no…

Microbiology (medical)MORTALITYInvasive candidiasiCandida; Intra-abdominal infection; Invasive candidiasis; Risk factorsCONTROLLED-TRIALCASPOFUNGINCANDIDEMIAInvasive candidiasisInfectious Diseaseslnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]Intra-abdominal infectionRisk factorsINFECTIONSMANAGEMENTEPIDEMIOLOGYPREDICTORSCONSENSUSCRITICALLY III PATIENTSCandida
researchProduct

Evaluation of the Architect Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG, VCA IgM, and EBV Nuclear Antigen 1 IgG Chemiluminescent Immunoas…

2014

ABSTRACTCommercial immunoassays for detecting IgG and IgM antibodies against Epstein-Barr virus (EBV), viral capsid antigens (VCA), and IgGs toward EBV nuclear antigen-1 (EBNA-1) are routinely used in combination to categorize EBV infection status. In this study, we evaluated the performances of the Architect EBV VCA IgG, VCA IgM, and EBNA-1 IgG chemiluminescent microparticle assays (CMIAs) in EBV serological analyses using indirect immunofluorescence assays and anticomplement immunofluorescence assays as the reference methods for VCA IgG, VCA IgM, and EBNA-1 IgG antibody detection, respectively. A total of 365 serum samples representing different EBV serological profiles were included in t…

Microbiology (medical)MaleEpstein-Barr Virus InfectionsHerpesvirus 4 HumanClinical BiochemistryImmunologyFluorescent Antibody Techniquemedicine.disease_causeImmunofluorescenceAntibodies ViralSensitivity and SpecificityImmunoglobulin GSerologyAntigenhemic and lymphatic diseasesDiagnostic Laboratory Immunologyotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansChildAntigens ViralImmunoassaymedicine.diagnostic_testbiologybusiness.industryDiagnostic Tests RoutineInfantVirologyEpstein–Barr virusstomatognathic diseasesEpstein-Barr Virus Nuclear AntigensImmunoglobulin MImmunoglobulin MImmunoassayChild PreschoolImmunoglobulin GImmunologyLuminescent Measurementsbiology.proteinCapsid ProteinsFemaleAntibodybusiness
researchProduct

Diagnosis of human immunodeficiency virus (HIV) infection: multicenter evaluation of a newly developed anti-HIV 1 and 2 enzyme immunoassay.

1994

A new anti-human immunodeficiency virus type 1 and 2 (anti-HIV 1 and 2) test is described. It uses recombinant p24 and peptides covering gp32, gp41, and gp120 to identify HIV-1 and HIV-2 infections. This test has been shown to be specific (99.5%) and sensitive (99.8%). In this respect, the assay was equal or superior to anti-HIV 1 and 2 tests run as references. The test was able to discriminate sera from patients with HIV infections from those from uninfected individuals with excellence; it also exerted high intra- and interassay precisions. The "modular" concept of the test allows the use of single components (gp32 or gp41) to separate between HIV-2 and HIV-1 infections, respectively.

Microbiology (medical)MaleHIV AntigensHIV InfectionsHIV AntibodiesGp41Sensitivity and SpecificityVirusDiagnosis DifferentialImmunoenzyme TechniquesAcquired immunodeficiency syndrome (AIDS)PregnancyImmunopathologyHIV SeropositivityMedicineHumansSidamedicine.diagnostic_testbiologybusiness.industryvirus diseasesmedicine.diseasebiology.organism_classificationVirologyRecombinant ProteinsHIV AntigensEvaluation Studies as TopicImmunoassayImmunologyHIV-2HIV-1FemaleViral diseasebusinessResearch ArticleJournal of clinical microbiology
researchProduct

Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.

2006

Toll-like receptor 4 (TLR4) is required for efficient recognition of bacterial infections. We investigated an association between 2 TLR4 mutations (Asp 299 Gly and Thr 399 Ile) and meningococcal disease in 197 patients and 214 healthy controls by allele-specific real time polymerase chain reaction and direct sequencing. Although the allele frequency was not higher in the overall patient population, a significantly higher frequency in the 40 patients younger than 12 months of age (P = 0.007) was observed. We conclude that TLR4 mutations represent a risk factor for meningococcal disease in this age group.

Microbiology (medical)MaleMutation MissenseMeningococcal diseasemedicine.disease_causePolymerase Chain ReactionGene FrequencyMedicineHumansGenetic Predisposition to DiseaseRisk factorReceptorChildAllele frequencyAllelesToll-like receptorMutationbusiness.industryAge FactorsInfantDNASequence Analysis DNAmedicine.diseaseEuropeMeningococcal InfectionsToll-Like Receptor 4Infectious DiseasesReal-time polymerase chain reactionAmino Acid SubstitutionChild PreschoolPediatrics Perinatology and Child HealthImmunologyTLR4FemalebusinessThe Pediatric infectious disease journal
researchProduct

Actinomadura pelletieri mycetoma--an atypical case with spine and abdominal wall involvement.

2011

We describe a case of mycetoma caused by Actinomadura pelletieri with simultaneous involvement of the spine, abdominal wall and retroperitoneal space in a man who had suffered from ‘Madura foot’ 10 years earlier. The characteristics of this case were analysed and contextualized among those of other cases of mycetoma caused by other micro-organisms found through a review of the international literature. The rarity of the disease in industrialized countries and its possible atypical presentations may hinder a prompt diagnosis. Culture techniques that allow detection of slow-growing fungi and actinomycetes should be routinely used when dealing with tissue samples from patients from tropical an…

Microbiology (medical)MalePathologymedicine.medical_specialtyTime FactorsChronic granulomatousMolecular Sequence DataBiologyMicrobiologymycetoma; Actinomadura pelletieriDisease courseAbdominal wallRecurrenceRNA Ribosomal 16SActinomadura pelletieriActinomycetalesmedicineInternational literatureRetroperitoneal spaceHumansMycetomaAbdominal WallActinomadura pelletieriGeneral MedicineMiddle AgedSpineRNA Bacterialmedicine.anatomical_structureAbdomenActinomycetales InfectionsmycetomaJournal of medical microbiology
researchProduct

Pathology of Rotavirus-driven Multiple Organ Failure in a 16-month-old Boy

2019

International audience; Autopsy investigation of a fatal case of rotavirus severe acute gastroenteritis and multiple organ failure in a 16-month boy with previous intrauterine growth retardation showed colocalization of nonstructural and structural rotavirus proteins within viroplasms in nephrons. This case brings new insights into extraintestinal rotavirus infection and new clues to its abilities to bind to human histo-blood group antigens.

Microbiology (medical)MaleRotavirusFatal outcomeMultiple Organ FailureAutopsymedicine.disease_causeRotavirus Infections03 medical and health sciences0302 clinical medicineFatal OutcomeAntigen[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases030225 pediatricsRotavirusmedicineHumans030212 general & internal medicineHuman histo-blood group antigens[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/PediatricsFetal Growth RetardationGrowth retardationbusiness.industryRotavirus severe acute gastroenteritisInfantvirus diseases[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyNephronsAcute gastroenteritisAcute Kidney InjuryShock Septic3. Good healthGastroenteritisRotavirus infectionInfectious DiseasesPediatrics Perinatology and Child HealthImmunologyAutopsybusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany: A Retrospective, Hospital-based Surveillance.

2015

Background Representative, population-based epidemiologic data for gastroenteritis caused by rotavirus (RV) are rare. RV vaccines were first licensed in Europe in 2006 and recommended in 5 western federal states in 2008 or thereafter. This study establishes a baseline for assessing the impact of vaccination and delineates the RV disease burden in Germany today. Methods Nationwide data obtained from hospitals for children 0 to 10 years of age and transferred to the Federal Statistical Office were analyzed retrospectively. Acute gastroenteritis cases because of RV were identified by the International Classification of Diseases code (ICD-10) combined with the referring diagnosis-related group …

Microbiology (medical)MaleRotavirusPediatricsmedicine.medical_specialtyPopulationmedicine.disease_causeRotavirus Infections03 medical and health sciencessymbols.namesake0302 clinical medicinePublic health surveillanceCost of Illness030225 pediatricsRotavirusGermanymedicineOdds RatioHumansPublic Health Surveillance030212 general & internal medicinePoisson regressionGeography MedicaleducationChildDisease burdenRetrospective Studieseducation.field_of_studybusiness.industryInfant NewbornRotavirus VaccinesInfantRetrospective cohort studyOdds ratioGastroenteritisVaccinationHospitalizationInfectious DiseasesChild PreschoolPediatrics Perinatology and Child HealthsymbolsFemalebusinessThe Pediatric infectious disease journal
researchProduct

Effect of cytomegalovirus (CMV) serostatus on the incidence and virological features of active CMV infection in allogeneic stem cell transplant recip…

2011

Microbiology (medical)Malebusiness.industryIncidence (epidemiology)Congenital cytomegalovirus infectionCytomegalovirusmedicine.diseaseVirologySeverity of Illness IndexTissue DonorsInfectious DiseasesCytomegalovirus InfectionsmedicineHumansFemaleVirus ActivationStem cellSerostatusbusinessStem Cell TransplantationClinical infectious diseases : an official publication of the Infectious Diseases Society of America
researchProduct

In vivo efficacy of humanised intermittent versus continuous ceftazidime in combination with tobramycin in an experimental model of pseudomonal pneum…

2008

In this study, we compared the efficacy of ceftazidime (CAZ) intermittent versus continuous infusion with or without tobramycin (TOB) for the treatment of pneumonia caused by Pseudomonas aeruginosa in rabbits. Treatments were humanised and mimicked intermittent CAZ (iCAZ) (2g three times daily), continuous CAZ (cCAZ) (4g once daily (qd)) and TOB (10mg/kg qd). Minimum inhibitory concentrations (MICs) were 1mg/L and 4mg/L for TOB and CAZ, respectively. Bacterial efficacy in lungs was as follows: control, 9+/-0.6 colony-forming units (CFU)/g; TOB monotherapy, 8+/-0.5CFU/g; iCAZ monotherapy, 7.8+/-1.4CFU/g; cCAZ monotherapy, 8+/-0.4CFU/g (P = 0.005); and iCAZ+TOB, 8+/-0.5CFU/g; cCAZ+TOB, 7.2+/-…

Microbiology (medical)Malemedicine.drug_classAntibioticsColony Count MicrobialCeftazidimeMicrobial Sensitivity TestsCeftazidimeMicrobiologyPseudomonas infectionmedicineTobramycinPneumonia BacterialAnimalsHumansPharmacology (medical)Pseudomonas InfectionsInfusions IntravenousLungAntibacterial agentProtein synthesis inhibitorbusiness.industryAminoglycosideGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesPharmacodynamicsTobramycinDrug Therapy CombinationRabbitsbusinessSpleenmedicine.drugInternational journal of antimicrobial agents
researchProduct